WealthCare Investment Partners LLC raised its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.1% in the second quarter, HoldingsChannel.com reports. The fund owned 8,275 shares of the financial services provider’s stock after purchasing an additional 94 shares during the quarter. WealthCare Investment Partners LLC’s holdings in iShares Biotechnology ETF were worth $1,051,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also bought and sold shares of IBB. Pacific Sun Financial Corp bought a new position in iShares Biotechnology ETF in the 2nd quarter valued at about $1,014,000. WJ Wealth Management LLC acquired a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $273,000. Etfidea LLC increased its stake in iShares Biotechnology ETF by 0.5% during the 2nd quarter. Etfidea LLC now owns 24,987 shares of the financial services provider’s stock valued at $3,172,000 after purchasing an additional 126 shares in the last quarter. Atlantic Union Bankshares Corp grew its stake in shares of iShares Biotechnology ETF by 2.5% in the 2nd quarter. Atlantic Union Bankshares Corp now owns 56,741 shares of the financial services provider’s stock worth $7,204,000 after acquiring an additional 1,370 shares in the last quarter. Finally, Brookstone Capital Management boosted its holdings in shares of iShares Biotechnology ETF by 29.0% in the 2nd quarter. Brookstone Capital Management now owns 2,559 shares of the financial services provider’s stock worth $318,000 after buying an additional 576 shares during the last quarter. 69.61% of the stock is owned by institutional investors.
iShares Biotechnology ETF Price Performance
NASDAQ IBB traded up $0.34 during trading on Tuesday, hitting $125.59. 725,462 shares of the company’s stock traded hands, compared to its average volume of 1,514,015. iShares Biotechnology ETF has a 12-month low of $113.37 and a 12-month high of $138.74. The business has a 50 day moving average of $128.05 and a 200-day moving average of $129.30.
About iShares Biotechnology ETF
iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.
- Five stocks we like better than iShares Biotechnology ETF
- Comparing and Trading High PE Ratio Stocks
- Hold-It-Forever AutoZone Pulls into Buy Zone
- There Are Different Types of Stock To Invest In
- Virtual Riches: 3 Stocks Leading the VR Revolution
- What Are Dividend Champions? How to Invest in the Champions
- 5 eCommerce Companies that need to be on Your Watch List
Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.